Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


PSNC seeks new CEO following Simon Dukes’s resignation from the role

PSNC has already started the recruitment process to appoint a new CEO, following Simon Dukes’s resignation from the role, it has announced.

Mr Dukes – who has served as the Pharmaceutical Services Negotiating Committee (PSNC) CEO for the past three years – will remain in post until the end of September, PSNC said in a statement this afternoon (July 20).

He will continue to lead on the work to agree on the arrangements on the 2021/22 pharmacy funding contract in England alongside the NHS and the government, PSNC said.

A PSNC spokesperson told C+D today that Mr Dukes will leave the top job at the English negotiating body to chair Fair for You, a not-for-profit online lending company.

PSNC has already started the recruitment process to hire Mr Dukes’s replacement and further information on this is expected “in due course”.

Stepping down now is “opportune”

Commenting on his resignation, Mr Dukes said that “deciding to step down was never going to be easy, but I do believe now is opportune”.

“It has been an honour to serve as chief executive of PSNC for the last three years, and a genuine privilege to work with such a dedicated, knowledgeable, and unbelievably hard-working senior team and committee,” he added.

Mr Dukes joined PSNC in 2018 from counter-fraud organisation CIFAS. During his tenure, he was responsible for leading the organisation on agreeing on a five-year funding settlement and helped support contractors during the pandemic.

Mr Dukes pointed to several highlights of his time as PSNC CEO, including improved relationships between the negotiator and NHS England & NHS Improvement and the Department of Health and Social Care; the settlement of COVID-19 costs for contractors; and the initiation of the independent review of both PSNC and local pharmaceutical committees.

“Demanding but rewarding role

Mr Dukes said his successor will be able to “engage fully with the changes that will emerge from the independent review”.

PSNC chair Sue Killen thanked Mr Dukes for “all that he has done, and is continuing to do, for community pharmacy”.

Being the PSNC CEO “is a demanding but hugely rewarding role, balancing the extensive stakeholder engagement work needed to support the sector, with the tactical side of the negotiations, and of course, leading a small and incredibly busy team doing complex but vital work”, Ms Killen added.

What do you make of this announcement?

Related Content


Pharmacy Manager

Apply Now
Latest News & Analysis
See All



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts